Home | Welcome to Contract Pharma   
Last Updated Saturday, December 20 2014

Print

Breaking News

Related Searches:
May 12, 2011
Dr. Dorla Mirejovsky has been appointed senior director of Formulation Development at Irvine Pharmaceutical Services.  Read More »
May 12, 2011
SilenceSelect tech to assist CNS research  Read More »
May 12, 2011
Service revenues rise, lead to net profit  Read More »
May 11, 2011
Michael E. Lytton has been appointed Patheon’s executive vice president of Corporate Development and Strategy and general counsel.  Read More »
May 11, 2011
Halozyme Therapeutics and ViroPharma have signed a worldwide exclusive licensing agreement for the use of rHuPH20 (recombinant human hyaluronidase) for the development of a subcutaneous formulation of Cinryze.   Read More »
May 11, 2011
ICON has entered a strategic alliance with Boston Clinical Research Institute (BCRI), an Academic Research Organization.   Read More »
May 11, 2011
EMD Millipore, the Life Science division of Merck KGaA, has opened its Biopharmaceutical Technical and Training Center in Shanghai, China.  Read More »
May 11, 2011
Immunologix and DavosPharma have formed a strategic alliance under which DavosPharma will represent and market human antibodies produced by Immunologix.  Read More »
May 11, 2011
Hovione has recently undergone six successful GMP inspections by major government agencies in the past eight months.   Read More »
May 11, 2011
Dutch bio-CMO to make bulk substance and product for trials  Read More »
May 11, 2011
Manufacturing outpaces lab services growth  Read More »
May 10, 2011
PPD, Inc. has established four practice areas through PPD Consulting: biosimilars, adaptive trial design, China regulatory strategy and cardiovascular outcomes studies.   Read More »
May 10, 2011
Pfenex, Inc. has entered a three-year strategic collaboration with MedImmune, the global biologics business of AstraZeneca, granting MedImmune non-exclusive access to Pfenex Expression Technology and resources for the development of bioprocesses for thera  Read More »
May 10, 2011
Randox, a supplier of biomarker discovery services for the development of new biomarker assays, companion diagnostics, and the manufacture of clinical diagnostic reagents, has recently developed QuantiPlasma Array, a monoclonal antibody microarray designe  Read More »
May 10, 2011
Onyx Scientific has been award a contract from Cancer Research UK to develop the chemistry and perform the GMP synthesis of an API for use in a Phase I trial.  Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On